Product Information
DIGOXIN 125 MCG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1327 per EA under NDC 70954020120. Its NADAC has been published 227 times since Jun 1, 2022.
FDA first approved this application on Nov 22, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.125 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954020120
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIGOXINApproval Type
Generic (ANDA)
FDA Application
ANDA215307FDA Approved
11/22/2021
TE Code
AB
On Market Since
11/22/2021
Pharmacological Classes
Price Statistics
The NADAC for DIGOXIN 125 MCG TABLET has been published 227 times since Jun 1, 2022, and over the history we have for it it has declined 43.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1327 per EA |
|---|---|
| All-time high | $0.2666 (Jul 13, 2022) |
| All-time low | $0.1064 (Jul 23, 2025) |
| 52-week high | $0.1327 |
| 52-week low | $0.1106 |
| Median price | $0.1569 |
| Average price | $0.1584 |
| Largest weekly change | -37.4% (Apr 17, 2024) |
| Weeks tracked | 227 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Digoxin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cardiac Glycoside class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIGOXIN 125 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIGOXIN 125 MCG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.1327 per EA (NDC 70954020120), effective Sep 30, 2026.
How has the price of DIGOXIN 125 MCG TABLET changed over time?
Over the history we have for it, the NADAC for DIGOXIN 125 MCG TABLET has declined 43.4%. It has been tracked across 227 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for DIGOXIN 125 MCG TABLET?
Since Jun 1, 2022, the NADAC for DIGOXIN 125 MCG TABLET has ranged from a low of $0.1064 (Jul 23, 2025) to a high of $0.2666 (Jul 13, 2022), with a median of $0.1569 per EA.
Are there cheaper alternatives to DIGOXIN 125 MCG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DIGOXIN 125 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DIGOXIN 125 MCG TABLET?
DIGOXIN 125 MCG TABLET (NDC 70954020120) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.